BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25458910)

  • 1. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis.
    Beigelman A; Isaacson-Schmid M; Sajol G; Baty J; Rodriguez OM; Leege E; Lyons K; Schweiger TL; Zheng J; Schechtman KB; Castro M; Bacharier LB
    J Allergy Clin Immunol; 2015 May; 135(5):1171-8.e1. PubMed ID: 25458910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.
    Beigelman A; Goss CW; Wang J; Srinivasan M; Boomer J; Zhou Y; Bram S; Casper TJ; Coverstone AM; Kanchongkittiphon W; Kuklinski C; Storch GA; Schechtman KB; Castro M; Bacharier LB
    Ann Allergy Asthma Immunol; 2024 May; 132(5):623-629. PubMed ID: 38237675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further clinical trials on macrolides for bronchiolitis in infants are unnecessary.
    McCallum GB; Chang AB; Grimwood K
    J Allergy Clin Immunol; 2015 Oct; 136(4):1134-5. PubMed ID: 26316096
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: To PMID 25458910.
    Beigelman A; Bacharier LB
    J Allergy Clin Immunol; 2015 Oct; 136(4):1135-6. PubMed ID: 26309182
    [No Abstract]   [Full Text] [Related]  

  • 5. The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population.
    Srinivasan M; Bacharier LB; Goss CW; Zhou Y; Boomer J; Bram S; Burgdorf D; Burnham CA; Casper T; Castro M; Coverstone A; Haslam M; Kanchongkittiphon W; Kuklinski C; Lian Q; Schechtman K; Storch GA; True K; Wallace MA; Yin-DeClue H; Ahrens E; Wang J; Beigelman A
    Contemp Clin Trials Commun; 2021 Jun; 22():100798. PubMed ID: 34189338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.
    Peng WS; Chen X; Yang XY; Liu EM
    Pediatr Allergy Immunol; 2014 Mar; 25(2):143-50. PubMed ID: 24118637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study.
    Bont L; Heijnen CJ; Kavelaars A; van Aalderen WM; Brus F; Draaisma JT; Geelen SM; Kimpen JL
    Am J Respir Crit Care Med; 2000 May; 161(5):1518-23. PubMed ID: 10806148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolomic profiling reveals important difference between infants with and without subsequent recurrent wheezing in later childhood after RSV bronchiolitis.
    Zhang X; Peng D; Zhang X; Wang X; Chen N; Zhao S; He Q
    APMIS; 2021 Mar; 129(3):128-137. PubMed ID: 33155332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD14 as a predictor of subsequent development of recurrent wheezing in hospitalized young children with respiratory syncytial virus-induced bronchiolitis.
    Soferman R; Bar-Zohar D; Jurgenson U; Fireman E
    Ann Allergy Asthma Immunol; 2004 May; 92(5):545-8. PubMed ID: 15191023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin therapy during respiratory syncytial virus bronchiolitis: Upper airway microbiome alterations and subsequent recurrent wheeze.
    Zhou Y; Bacharier LB; Isaacson-Schmid M; Baty J; Schechtman KB; Sajol G; Wylie K; Storch GA; Castro M; Beigelman A
    J Allergy Clin Immunol; 2016 Oct; 138(4):1215-1219.e5. PubMed ID: 27339392
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired tumor necrosis factor-α secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze.
    Kitcharoensakkul M; Bacharier LB; Yin-Declue H; Boomer JS; Sajol G; Leung MK; Wilson B; Schechtman KB; Atkinson JP; Green JM; Castro M
    Immun Inflamm Dis; 2020 Mar; 8(1):30-39. PubMed ID: 31901157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial.
    Tahan F; Ozcan A; Koc N
    Eur Respir J; 2007 Jan; 29(1):91-7. PubMed ID: 17050564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis.
    Zhang X; Zhang X; Zhang N; Wang X; Sun L; Chen N; Zhao S; He Q
    Pediatr Allergy Immunol; 2020 Apr; 31(3):281-289. PubMed ID: 31788862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation.
    Kim CK; Choi J; Kim HB; Callaway Z; Shin BM; Kim JT; Fujisawa T; Koh YY
    J Pediatr; 2010 May; 156(5):749-54. PubMed ID: 20171653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled nitric oxide in acute respiratory syncytial virus bronchiolitis.
    Gadish T; Soferman R; Merimovitch T; Fireman E; Sivan Y
    Arch Pediatr Adolesc Med; 2010 Aug; 164(8):727-31. PubMed ID: 20679163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus.
    van Woensel JB; Kimpen JL; Sprikkelman AB; Ouwehand A; van Aalderen WM
    Pediatr Pulmonol; 2000 Aug; 30(2):92-6. PubMed ID: 10922130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway.
    Fjaerli HO; Farstad T; Rød G; Ufert GK; Gulbrandsen P; Nakstad B
    BMC Pediatr; 2005 Aug; 5():31. PubMed ID: 16109158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations and rationale of the MAKI trial: a multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33-35 weeks.
    Blanken M; Rovers M; Sanders E; Bont L
    Contemp Clin Trials; 2012 Nov; 33(6):1287-92. PubMed ID: 22820319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life.
    Bont L; Steijn M; van Aalderen WM; Kimpen JL
    Pediatr Infect Dis J; 2004 May; 23(5):414-7. PubMed ID: 15131463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze.
    Schuurhof A; Janssen R; de Groot H; Hodemaekers HM; de Klerk A; Kimpen JL; Bont L
    Respir Res; 2011 Sep; 12(1):121. PubMed ID: 21910858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.